Peritoneal Tuberculosis and Granulomatous Hepatitis Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
Presented by:
Annals of Clinical Microbiology and Antimicrobials / Aliye Soylu, Ali T Ince, Hakan Polat, Nurgul Yasar, Aydin Ciltas, Selvinaz Ozkara and Ali I Tasci
Summary points:
This report describes 2 cases of serious side effects following intravesical administration of Bacillus Calmette-Guerin for the treatment of superficial bladder cancer. One is the second reported case of tubercular peritonitis and the second is a case of granulomatous hepatitis. The authors discuss strategies for monitoring for these side effects and possible treatment options.
Peritoneal Tuberculosis and Granulomatous Hepatitis Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
